Abstract
Recently, a natural compound leoligin, a furan-type lignan, was discovered as an interesting hit compound with an anti-inflammatory pharmacological activity profile. We developed a modular and stereoselective approach for the synthesis of the edelweiss-derived lignan leoligin and used the synthetic route to rapidly prepare leoligin analogs even on the gram scale. Proof of concept of this approach together with cell-based bio-assays gained structural analogs with increased selectivity towards vascular smooth muscle versus endothelial cell proliferation inhibition, a major benefit in fighting vascular neointima formation. In addition, we identified the structural features of leoligin analogs that define their ability to inhibit the pro-inflammatory NF-kappa B pathway. Results are discussed in the context of structural modification of these novel synthetic lignans.
| Dokumententyp: | Zeitschriftenartikel | 
|---|---|
| Fakultät: | Medizin | 
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit | 
| ISSN: | 2041-6520 | 
| Sprache: | Englisch | 
| Dokumenten ID: | 79758 | 
| Datum der Veröffentlichung auf Open Access LMU: | 15. Dez. 2021 14:49 | 
| Letzte Änderungen: | 15. Dez. 2021 14:49 | 
 
		 
	 
    


